TY - JOUR
T1 - Dissecting the heterogeneity of exhausted T cells at the molecular level
AU - Kagoya, Yuki
N1 - Publisher Copyright:
© 2022 The Author(s). Published by Oxford University Press on behalf of The Japanese Society for Immunology. All rights reserved.
PY - 2022/11/1
Y1 - 2022/11/1
N2 - Our understanding of mechanisms underlying T-cell exhaustion has been refined by analysis of exhausted T cells at the molecular level. The development and functions of exhausted T cells are regulated by a number of transcription factors, epigenetic factors and metabolic enzymes. In addition, recent work to dissect exhausted T cells at the single-cell level has enabled us to discover a precursor exhausted T-cell subset equipped with long-term survival capacity. Starting from the analysis of mouse models, the existence of precursor exhausted T cells has also been documented in human T cells in the context of chronic virus infections or tumors. Clinical data suggest that evaluating the quality of exhausted T cells on the basis of their differentiation status may be helpful to predict the therapeutic response to inhibition of programmed death 1 (PD1). Moreover, beyond immune-checkpoint blockade, novel therapeutic approaches to re-invigorate exhausted T cells have been explored based on molecular insights into T-cell exhaustion. Here I will discuss key molecular profiles associated with the development, maintenance and differentiation of exhausted T cells and how these findings can be applicable in the field of cancer immunotherapy.
AB - Our understanding of mechanisms underlying T-cell exhaustion has been refined by analysis of exhausted T cells at the molecular level. The development and functions of exhausted T cells are regulated by a number of transcription factors, epigenetic factors and metabolic enzymes. In addition, recent work to dissect exhausted T cells at the single-cell level has enabled us to discover a precursor exhausted T-cell subset equipped with long-term survival capacity. Starting from the analysis of mouse models, the existence of precursor exhausted T cells has also been documented in human T cells in the context of chronic virus infections or tumors. Clinical data suggest that evaluating the quality of exhausted T cells on the basis of their differentiation status may be helpful to predict the therapeutic response to inhibition of programmed death 1 (PD1). Moreover, beyond immune-checkpoint blockade, novel therapeutic approaches to re-invigorate exhausted T cells have been explored based on molecular insights into T-cell exhaustion. Here I will discuss key molecular profiles associated with the development, maintenance and differentiation of exhausted T cells and how these findings can be applicable in the field of cancer immunotherapy.
KW - cancer immunotherapy
KW - epigenetics
KW - memory T cell
KW - transcription factors
UR - http://www.scopus.com/inward/record.url?scp=85138929561&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85138929561&partnerID=8YFLogxK
U2 - 10.1093/intimm/dxac016
DO - 10.1093/intimm/dxac016
M3 - Review article
C2 - 35561668
AN - SCOPUS:85138929561
SN - 0953-8178
VL - 34
SP - 547
EP - 553
JO - International Immunology
JF - International Immunology
IS - 11
ER -